Crosstalk between Keratinocytes and Adaptive Immune Cells in an IκBα Protein-Mediated Inflammatory Disease of the Skin

Immunity

Volumn 27, Issue 2, 2007, Pages 296-307

  Rebholz, Bernd ^a   Haase, Ingo ^b   Eckelt, Birgit ^a   Paxian, Stephan ^c   Flaig, Michael J ^a   Ghoreschi, Kamran ^d   Nedospasov, Sergei A ^e   Mailhammer, Reinhard ^f   Debey Pascher, Svenja ^b   Schultze, Joachim L ^b   Weindl, Günther ^d   Förster, Irmgard ^g   Huss, Ralf ^h   Stratis, Athanasios ^b   Ruzicka, Thomas ^a   Röcken, Martin ^d   Pfeffer, Klaus ^g   Schmid, Roland M ^c   Rupec, Rudolf A ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^f INSTITUTE OF EPIDEMIOLOGY   (Germany)

^g HEINRICH HEINE UNIVERSITY   (Germany)

^h UNIVERSITY OF MUNICH   (Germany)

Author keywords

CELLIMMUNO; HUMDISEASE; MOLIMMUNO

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOTOXIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; GENE ACTIVATION; GENE DELETION; IMMUNOCOMPETENT CELL; INFLAMMATORY DISEASE; KERATINOCYTE; LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SKIN INFLAMMATION; T LYMPHOCYTE;

ABSCESS; ANIMALS; CELL COMMUNICATION; DERMATITIS; EPIDERMIS; GENE DELETION; I-KAPPA B PROTEINS; KERATINOCYTES; KERATINS; LYMPHOTOXIN-ALPHA; MICE; MICE, MUTANT STRAINS; SKIN; T-LYMPHOCYTES; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548047674     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2007.05.024     Document Type: Article

References (38)

1. Aggarwal B.B. Signalling pathways of the TNF superfamily: A double-edged sword. Nat. Rev. Immunol. 3 (2003) 745-756
2. Algül H., Treiber M., Lesina M., Nakhai H., Saur D., Geisler F., Pfeifer A., Paxian S., and Schmid R.M. Pancreas-specific RelA/p65 truncation increases susceptibility of acini to inflammation-associated cell death following cerulein pancreatitis. J. Clin. Invest. 117 (2007) 1490-1501
3. Austin L.M., Ozawa M., Kikuchi T., Walters I.B., and Krueger J.G. The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-γ, interleukin-2, and tumor necrosis factor-α, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: A type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J. Invest. Dermatol. 113 (1999) 752-759
4. Bowcock A.M. The genetics of psoriasis and autoimmunity. Annu. Rev. Genomics Hum. Genet. 6 (2005) 93-122
5. Bowcock A.M., and Krueger J.G. Getting under the skin: The immunogenetics of psoriasis. Nat. Rev. Immunol. 5 (2005) 699-711
6. Carroll J.M., Crompton T., Seery J.P., and Watt F.M. Transgenic mice expressing IFN-γ in the epidermis have eczema, hair hypopigmentation, and hair loss. J. Invest. Dermatol. 108 (1997) 412-422
7. Carroll J.M., Romero M.R., and Watt F.M. Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 83 (1995) 957-968
8. Cheng J., Turksen K., Yu Q.C., Schreiber H., Teng M., and Fuchs E. Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNFα transgenic mice. Genes Dev. 6 (1992) 1444-1456
9. Clausen B.E., Burkhardt C., Reith W., Renkawitz R., and Förster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8 (1999) 265-277
10. De Togni P., Goellner J., Ruddle N.H., Streeter P.R., Fick A., Mariathasan S., Smith S.C., Carlson R., Shornick L.P., Strauss-Schoenberger J., et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264 (1994) 703-707
11. Ghoreschi K., Thomas P., Breit S., Dugas M., Mailhammer R., van Eden W., van der Zee R., Biedermann T., Prinz J., Mack M., et al. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat. Med. 9 (2003) 40-46
12. Gudjonsson J.E., Johnston A., Sigmundsdottir H., and Valdimarsson H. Immunopathogenic mechanisms in psoriasis. Clin. Exp. Immunol. 135 (2004) 1-8
13. Hayden M.S., and Ghosh S. Signaling to NF-κB. Genes Dev. 18 (2004) 2195-2224
14. Hennet T., Hagen F.K., Tabak L.A., and Marth J.D. T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl- transferase gene by site-directed recombination. Proc. Natl. Acad. Sci. USA 92 (1995) 12070-12074
15. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu. Rev. Immunol. 18 (2000) 621-663
16. Karin M., and Greten F.R. NF-κB: Linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5 (2005) 749-759
17. Komine M., Rao L.S., Freedberg I.M., Simon M., Milisavljevic V., and Blumenberg M. Interleukin-1 induces transcription of keratin K6 in human epidermal keratinocytes. J. Invest. Dermatol. 116 (2001) 330-338
18. Koo J., and Khera P. Update on the mechanisms and efficacy of biological therapies for psoriasis. J. Dermatol. Sci. 38 (2005) 75-87
19. Kuprash D.V., Alimzhanov M.B., Tumanov A.V., Grivennikov S.I., Shakhov A.N., Drutskaya L.N., Marino M.W., Turetskaya R.L., Anderson A.O., Rajewsky K., et al. Redundancy in tumor necrosis factor (TNF) and lymphotoxin (LT) signaling in vivo: Mice with inactivation of the entire TNF/LT locus versus single-knockout mice. Mol. Cell. Biol. 22 (2002) 8626-8634
20. Lang K.S., Recher M., Junt T., Navarini A.A., Harris N.L., Freigang S., Odermatt B., Conrad C., Ittner L.M., Bauer S., et al. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat. Med. 11 (2005) 138-145
21. Lawrence C.M., and Shuster S. Therapeutic effect of anthralin. J. Am. Acad. Dermatol. 26 (1992) 138-139
22. Li Q., and Verma I.M. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2 (2002) 725-734
23. Nestle F.O., Turka L.A., and Nickoloff B.J. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. J. Clin. Invest. 94 (1994) 202-209
24. Nickoloff B.J., and Wrone-Smith T. Animal models of psoriasis. Nat. Med. 3 (1997) 475-476
25. Pasparakis M., Alexopoulou L., Episkopou V., and Kollias G. Immune and inflammatory responses in TNFα-deficient mice: A critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184 (1996) 1397-1411
26. Pasparakis M., Courtois G., Hafner M., Schmidt-Supprian M., Nenci A., Toksoy A., Krampert M., Goebeler M., Gillitzer R., Israël A., et al. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417 (2002) 861-866
27. Pfeffer K. Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev. 14 (2003) 185-191
28. Pfeffer K., Matsuyama T., Kundig T.M., Wakeham A., Kishihara K., Shahinian A., Wiegmann K., Ohashi P.S., Kronke M., and Mak T.W. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73 (1993) 457-467
29. Robert C., and Kupper T.S. Inflammatory skin diseases, T cells, and immune surveillance. N. Engl. J. Med. 341 (1999) 1817-1828
30. Roper E., Weinberg W., Watt F.M., and Land H. p19ARF-independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes. EMBO Rep. 2 (2001) 145-150
31. Rupec R.A., Jundt F., Rebholz B., Eckelt B., Weindl G., Herzinger T., Flaig M.J., Moosmann S., Plewig G., Dörken B., et al. Stroma-mediated dysregulation of myelopoiesis in mice lacking IκBα. Immunity 22 (2005) 479-491
32. Sano S., Chan K.S., Carbajal S., Clifford J., Peavey M., Kiguchi K., Itami S., Nickoloff B.J., and DiGiovanni J. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat. Med. 11 (2005) 43-49
33. Schön M.P. Animal models of psoriasis - what can we learn from them?. J. Invest. Dermatol. 112 (1999) 405-410
34. Schwenk F., Baron U., and Rajewsky K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP- flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23 (1995) 5080-5081
35. Tarutani M., Itami S., Okabe M., Ikawa M., Tezuka T., Yoshikawa K., Kinoshita T., and Takeda J. Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development. Proc. Natl. Acad. Sci. USA 94 (1997) 7400-7405
36. Viatour P., Merville M.P., Bours V., and Chariot A. Phosphorylation of NF-κB and IκB proteins: Implications in cancer and inflammation. Trends Biochem. Sci. 30 (2005) 43-52
37. Wrone-Smith T., and Nickoloff B.J. Dermal injection of immunocytes induces psoriasis. J. Clin. Invest. 98 (1996) 1878-1887
38. Zhang J.Y., Green C.L., Tao S., and Khavari P.A. NF-κB RelA opposes epidermal proliferation driven by TNFR1 and JNK. Genes Dev. 18 (2004) 17-22